II. Background
- Pregnancy Categories will be replaced on medication bottles with specific warnings and precautions by 2020 in U.S.- http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm425317.htm
- Although FDA Pregnancy Categories are no longer listed, they are included here- As of 2018, succinct guidance (to replace ABCDX) on specific drugs in pregnancy is lacking
 
 
III. Preparations: Upper Respiratory Medications
- See Upper Respiratory Medications in Pregnancy
- First-generation Antihistamines (Sedating Antihistamines)- Diphenhydramine (Benadryl)- FDA Category B
- Crosses placenta
- Risk of Oxytocin-like effects at high dose
 
- Brompheniramine- FDA Category C
 
- Chlorpheniramine- FDA Category C
- Considered as a first-choice Sedating Antihistamine in pregnancy
 
- Pheniramine- FDA Category C
 
 
- Diphenhydramine (Benadryl)
- Second-generation Antihistamines (Non-Sedating Antihistamines)- Cetirizine (Zyrtec)- FDA Category B
 
- Loratadine (Claritin)- FDA Category B
 
- Fexofenadine (Allegra)- FDA Category C
 
 
- Cetirizine (Zyrtec)
- 
                          Decongestants- Phenylephrine- FDA Category C
- Crosses placenta (avoid in first trimester)
 
- Pseudoephedrine- FDA Category C
- Associated with Gastroschisis, small Intestinal Atresia and hemifacial microsomia (avoid in first trimester)
 
 
- Phenylephrine
- Expectorants- Guaifenesin- FDA Category C
- No safety data available (avoid in first trimester)
 
 
- Guaifenesin
- 
                          Cough Suppressants- Dextromethorphan- FDA Category C
 
 
- Dextromethorphan
IV. Preparations: Analgesics and antipyretics
- 
                          Acetaminophen
                          - Crosses the placenta
- FDA Category B (first-choice agent)
 
- 
                          Aspirin
                          - Crosses the placenta
- Avoid in pregnancy overall unless specifically indicated (e.g. Preeclampsia Prevention)
- FDA Category C in first and second trimester
- FDA Category D in third trimester (avoid)
 
- 
                          NSAIDS (Naproxen, Ibuprofen)- Crosses the placenta
- Avoid in first trimester due to risk of orofacial clefts (Naproxen), cardiac defects and Transposition of the Great Vessels
- FDA Category C in first and second trimester
- FDA Category D in third trimester (avoid due to premature ductus arteriosus closure and oligohydramnios risk)
 
V. Preparations: Gastrointestinal medications
- 
                          Antacids- Cimetidine (Tagamet)- FDA Category B
- Crosses the placenta
- Weak Androgenic Activity in animal studies
- Zantac may be preferred for longerterm use
 
- Famotidine (Pepcid)- FDA Category B (based on limited human data)
- Crosses the placenta
 
- Nizatidine (Axid)- Crosses the placenta
- Avoid in pregnancy
- Risk of IUGR, fetal death and abortion seen in rabbit studies
 
- Ranitidine (Zantac)- FDA Category B
- Crosses the placenta
 
- Proton Pump Inhibitors- Crosses the placenta
- FDA Category B as a class including Esomeprazole (Nexium), Rabeprazole (Aciphex) and Lansoprazole (Prevacide)
- FDA Category C for Omeprazole (Prilosec) based on animal studies- However, appears safe in pregnancy and is best studied of the PPI agents
 
 
- Aluminum hydroxide- Pregnancy risk class is unknown, but appears safe in pregnancy
- Neurotoxicity risk at high dose
 
- Calcium Carbonate- Pregnancy risk class is unknown, but appears safe in pregnancy
- First choice agent of the Antacids in pregnancy
- Crosses the placenta
- Risk of Milk-Alkali Syndrome at high dose
 
- Magnesium Hydroxide (or Magnesium carbonate)- Pregnancy risk class is unknown, but appears safe in pregnancy
 
 
- Cimetidine (Tagamet)
- Anti-gas agents- Simethicone- FDA Category B
- Not absorbed and does not cross the placenta, so considered safe in pregnancy
 
 
- Simethicone
- Anti-Diarrheals- Bismuth Subsalicylate (Pepto-Bismol)- FDA Category C
- Avoid in pregnancy (especially second and third trimester due to Aspirin component)
 
- Loperamide (Imodium)- FDA Category C
- Possible associations with cardiovascular defects
 
 
- Bismuth Subsalicylate (Pepto-Bismol)
- 
                          Laxatives- Mineral Oil- FDA Category C
- Not absorbed (and does not cross the placenta)
- Avoid in pregnancy
- Risk of fat soluble Vitamin Decreased absorption (risk of neonatal Coagulopathy and bleeding complications)
 
- Castor Oil- FDA Category X (absolutely contraindicated in pregnancy)
- Avoid in pregnancy due to risks to both mother and child
 
- Polyethylene Glycol 3350 (Miralax)- FDA Category C
- Preferred Laxative for Constipation in Pregnancy
 
 
- Mineral Oil
VI. Preparations: Herbals
- Herbal agents that appear safe in pregnancy- Echinacea
- Glucosamine- Used for Joint Pain
 
- Ginger- Appears effective for Morning Sickness
- Appears safe in pregnancy- Early reports of Spontaneous Abortion and Preterm Labor were not found in larger trials
 
 
 
- Herbal agents that may result in Miscarriage via uterine stimulation (avoid)- Mugwort
- Blue Cohosh
- Black Cohosh
- Goldenseal
- Juniper berry
- Chaste berry
- Rue
- Pennyroyal oil
 
- Herbal agents that are considered unsafe in pregnancy (avoid)- St. John's Wort- Lack of safety data
 
- Feverfew- Inhibits Platelet aggregation
- Inhibits prostglandin production
 
- Ephedra- Anencephaly risk
- Transposition of the Great Vessels risk
- Aortic Stenosis risk
 
 
- St. John's Wort
VII. Preparations: Topical Dermatologic Preparations
- 
                          Topical Antifungal agents- Topical Imidazoles (Miconazole, Clotrimazole)- Absorption varies depending on concentration
- Well studied and appear safe in pregnancy
 
- Topical Nystatin- Minimal absorption
- Well studied and appears safe in pregnancy
 
- Topical Terbinafine (Lamisil)- Topical Terbinafine has not been studied, but oral Terbinafine is FDA Catetegory B
 
 
- Topical Imidazoles (Miconazole, Clotrimazole)
- 
                          Topical Corticosteroids- Hydrocortisone 1%- Absorption varies to a maximum of 7%
- Appears safe in pregnancy, but limit to smallest area of needed application, and shortest duration of use
 
 
- Hydrocortisone 1%
- 
                          Topical Antibiotics- Topical Bacitracin- Appears safe in pregnancy
 
 
- Topical Bacitracin
- Topical acne agents- Topical Benzoyl Peroxide- Appears safe in pregnancy (despite low levels of absorption up to 5%)
 
 
- Topical Benzoyl Peroxide
VIII. References
- Briggs (2008) Drugs in Pregnancy and Lactation, Lippincott Williams and Wilkins, Philadelphia, PA
- Servey (2014) Am Fam Physician 90(8): 548-55 [PubMed]
